Patents by Inventor Myeongjoong Kim

Myeongjoong Kim has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND
    Publication number: 20230201164
    Abstract: The present disclosure relates to a pharmaceutical composition containing a benzimidazole derivative compound. Specifically, the present disclosure relates to a formulation capable of maintaining a sustained blood concentration of the benzimidazole derivative compound.
    Type: Application
    Filed: February 26, 2021
    Publication date: June 29, 2023
    Inventors: Suchul LEE, Eun Kyung JEON, Young Dae CHO, Sung Ah LEE, Dong Hyun KIM, Myeongjoong KIM, So Hyun JOO, Bong Tae KIM
  • Heterocyclic compound as a protein kinase inhibitor
    Patent number: 11524968
    Abstract: The present invention provides a novel compound having a protein kinase inhibition activity, a stereoisomer thereof or a pharmaceutically acceptable salt thereof. The compound, the stereoisomer thereof or the pharmaceutically acceptable salt thereof according to the present invention show a protein kinase inhibition activity, thus being effective in preventing or treating diseases related to protein kinase, such as cancer, autoimmune disease, neurological disease, metabolic disease, infection or the like.
    Type: Grant
    Filed: October 17, 2018
    Date of Patent: December 13, 2022
    Assignee: HK inno.N Corporation
    Inventors: Hyuk Woo Lee, Mi Kyung Ji, Seung Chan Kim, Ha Na Yu, Soo Yeon Jung, Ji-Yeon Park, Ye-Lim Lee, Ho-Youl Lee, So Young Ki, Dongkyu Kim, Myeongjoong Kim
  • PHARMACEUTICAL COMPOSITION COMPRISING BENZIMIDAZOLE DERIVATIVE COMPOUND
    Publication number: 20220125764
    Abstract: The present invention relates to a pharmaceutical composition for preventing the recurrence of gastroesophageal reflux disease, comprising a benzimidazole derivative. The pharmaceutical composition of the present invention may effectively prevent the recurrence of gastroesophageal reflux disease without any side effects for a long period of time.
    Type: Application
    Filed: February 17, 2020
    Publication date: April 28, 2022
    Applicant: HK INNO.N CORPORATION
    Inventors: Bong Tae KIM, Hyun Kyung LEE, Ji Yeon NAM, Mi Hwa OH, Geun Seog SONG, Myeongjoong KIM
  • Heterocyclic Compound as a Protein Kinase Inhibitor
    Publication number: 20210171544
    Abstract: The present invention provides a novel compound having a protein kinase inhibition activity, a stereoisomer thereof or a pharmaceutically acceptable salt thereof. The compound, the stereoisomer thereof or the pharmaceutically acceptable salt thereof according to the present invention show a protein kinase inhibition activity, thus being effective in preventing or treating diseases related to protein kinase, such as cancer, autoimmune disease, neurological disease, metabolic disease, infection or the like.
    Type: Application
    Filed: October 17, 2018
    Publication date: June 10, 2021
    Inventors: Hyuk Woo Lee, Mi Kyung Ji, Seung Chan Kim, Ha Na Yu, Soo Yeon Jung, Ji-Yeon Park, Ye-Lim Lee, Ho-Youl Lee, So Young KI, Dongkyu Kim, Myeongjoong Kim